تصفح حسب المؤلف "Kong, David C.M."
-
Authors’ Reply to Denning: Comment on: “Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries”
Pathadka, Swathi; Yan, Vincent K.C.; Neoh, Chin Fen; Al-Badriyeh, Daoud; Kong, David C.M.; Slavin, Monica A.; Cowling, Benjamin J.; Hung, Ivan F.N.; Wong, Ian C.K.; Chan, Esther W.... more authors ... less authors ( Springer , 2022 , Other)thank you for the opportunity to respond to the comments raised in Prof. Denning’s letter. We also thank Prof. Denning for taking an interest in our paper and speculating on possibilities for an increase in itraconazole ... -
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries
Pathadka, Swathi; Yan, Vincent K.C.; Neoh, Chin Fen; Al-Badriyeh, Daoud; Kong, David C.M.; Slavin, Monica A.; Cowling, Benjamin J.; Hung, Ivan F.N.; Wong, Ian C.K.; Chan, Esther W.... more authors ... less authors ( Springer , 2022 , Article)Background: Understanding the trend of global antifungal agent consumption could assist with identification of global healthcare policy inadequacies and promote accessibility and availability of antifungal agents. Methods: ... -
Open-label study of absorption and clearance of 1% voriconazole eye drops
Neoh, Chin Fen; Leung, Lok; Chan, Elsie; Al-Badriyeh, Daoud; Fullinfaw, Robert O.; Jhanji, Vishal; Vajpayee, Rasik B.; Davies, Geoffrey E.; Stewart, Kay; Kong, David C. M.... more authors ... less authors ( American Society for Microbiology , 2016 , Article)Twenty participants undergoing elective cataract surgery received 1% voriconazole eye drops (1 drop per eye) either 20, 40, 60, or 80 min before surgery. Median voriconazole concentrations of 1.9 to 3.2 mg/liter in aqueous ... -
Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia
Al-Badriyeh, Daoud; Liew, Danny; Stewart, Kay; Kong, David C. M. ( Blackwell Publishing Ltd , 2012 , Article)In two major clinical trials, voriconazole and caspofungin were recommended as alternatives to liposomal amphotericin B for empirical use in febrile neutropenia. This study investigated the health economic impact of using ...